
               
               
               7 DRUG INTERACTIONS
               
                  Whenever possible, agents which may enhance the risk of hemorrhage should be discontinued prior to initiation of Lovenox therapy.  These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, salicylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.  If co-administration is essential, conduct close clinical and laboratory monitoring [see 
                        Warnings and Precautions (5.9)
                     ].
               
               
               
                  
                     
                        Discontinue agents which may enhance hemorrhage risk prior to initiation of Lovenox or conduct close clinical and laboratory monitoring (5.9, 7)
                     
                  
               
            
         